HealthTree Cure Tour: Syracuse, NY (In-Person) with Drs. Malek and Ghimire

Name: HealthTree Cure Tour: Syracuse, NY (In-Person) with Drs. Malek and Ghimire
Start: 2024-05-02T17:30:00-04:00
End: 2024-05-02T19:30:00-04:00

HealthTree Cure Tour: Syracuse, NY (In-Person) with Drs. Malek and Ghimire

HealthTree Foundation for Multiple Myeloma

May 02, 2024 / 05:30PM - 07:30PM EDT

Upstate Cancer Center, 750 E Adams St, - Syracuse, New York

Event Description

HealthTree Foundation creates innovative tools that save lives. Join us for our in person Syracuse workshop on May 2 to learn more about HealthTree and HealthTree Cure Hub – a powerful, free tool that helps you manage your disease and contribute to cures.

Dr. Ehsan Malek from Roswell Park Comprehensive Cancer Center and Dr. Krishna Ghimire from Upstate Cancer Center will be on hand to talk about their work in myeloma and blood cancers, new ways patients can participate in research, and answer your questions.

There is no cost to attend. Registration, parking, and a light dinner are free. This meeting is open to patients with multiple myeloma, lymphoma, leukemia and MPNs.

This event will not be recorded.

Why Attend?

Learn all the ways HealthTree Cure Hub technology works for you:

Meeting Details

Meeting date: Thursday, May 2nd, 2024 at 5:30 PM
Location: 750 E Adams St, Syracuse, NY 13210, USA, Upstate Cancer Center, 1st floor conference room C1076 A/B/C
Registration, parking, and a light dinner are free
Please bring your laptop and any necessary passwords to open or use your computer

Questions?

For questions about registration, contact us at +1-800-709-1113 or support@healthtree.org.

For all other questions, contact curetour@healthtree.org.

Speakers & Moderators

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Ehsan Malek, MD

My research interest is primarily in enhancing CAR technology and understanding resistance mechanisms. I believe the immunotherapies relying on MM patients’ native immune system has limitations given chronic immune cell exhaustion in all settings of Myeloma; CAR, as a synthetic structure that does not exist in nature, enables us to genetically engineer patients’ immune cells to attack Myeloma cells using different cancer-specific targets. Boldy enough, I see enhancing CAR efficacy as the only path for cure.

Read Bio

Krishna B. Ghimire, MD

Krishna B. Ghimire is the Assistant Professor of Medicine at Upstate Cancer Center. He specializes in Hematology and Oncology. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice between 11-20 years. Dr. Krishna B. Ghimire has expertise in treating lymphoma, lung cancer, chronic leukemia, among other conditions

Read Bio